Clinical Trials Disclosure and Transparency Summit Presentations
Click on the presentation title to view the presentation
DAY ONE: TUESDAY, JULY 23, 2013 |
|
9:45 a.m. – 10:15 a.m. |
Keynote: CDER’s Views on Clinical Trial Disclosure and Transparency Dr. Richard Moscicki, Deputy Center Director for Science Operations, CDER, FDA |
10:15 a.m. – 11:00 a.m. |
Keynote: Open Clinical Trial Data for All? Sir Alasdair Breckenridge, M.D., Chair, Emerging Science and Bioethics Advisory Committee, Department of Health, UK |
11:30 a.m. – 1:15 p.m. |
Interactive Panel Discussion: Got Registered Trials? Seeking Common Ground Between Medical Journal Editors and Industry (No slides for this session) Moderator: Peter Pitts, President, Co-founder, Center for Medicine in the Public Interest Panelists:
|
2:30 p.m. – 3:30 p.m. |
Trial Transparency and Participant Level Data Dr. Deborah Zarin, Director, ClinicalTrials.gov |
3:45 p.m. – 5:30 p.m. |
Interactive Panel Discussion: Beyond Basic Research — Understanding Patient Advocacy And The Push To Help Shape The Process (No slides for this session) Moderator: Peter Pitts, President, Co-founder, Center for Medicine in the Public Interest Panelists:
|
DAY TWO: WEDNESDAY, JULY 24, 2013 |
|
9:45 a.m. – 10:30 a.m. |
Understanding Data Sharing And Investigator Databanks To Improve Clinical Research Dr. Garry Neil, Partner, Apple Tree Partners; formerly Corporate Vice President, Science & Technology, Johnson & Johnson |
10:30 a.m. – 11:15 a.m. |
Dr. Joseph Ross, Co-Investigator, Open Data Access Project, Yale University |
11:30 a.m. – 12:15 p.m. |
Christopher Dedels, Global Product Manager, Clinical Trial Disclosure Solutions, Virtify |